Thermodynamics of phosphopeptide tethering to BRCT: The structural minima for inhibitor design

被引:27
作者
Lokesh, G. L. [1 ]
Muralidhara, B. K. [1 ]
Negi, Surendra S. [1 ]
Natarajan, Amarnath [1 ]
机构
[1] Univ Texas, Med Branch, Sealy Ctr Struct Biol, Dept Pharmacol & Toxicol,Chem Biol Program, Galveston, TX 77555 USA
关键词
D O I
10.1021/ja0739178
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Protein-protein interactions mediated by the carboxy terminus domains of breast cancer gene 1 (BRCT) play a critical role in the regulation of cell cycle checkpoints in response to DNA damage. DNA damage-induced checkpoint regulation bestows radiation resistance to cancers, and inhibition of the proteins involved has been suggested as potential drug targets. Structural studies show that BRCT binding peptides, namely BACH1 and CUP that are important for cell cycle regulation, occupy the exact same site on BRCT through a pSXXF consensus recognition sequence. In the present study we use two complementary techniques, isothermal titration calorimetry (ITC) and fluorescence polarization (FP), to define structural minima of a BACH1 peptide. Remarkably the minimal tetrapeptide retains low-micromolar affinity for BRCT with a thermodynamic signature comparable to the decapeptide. The study also identifies a potential hydrophobic pocket adjacent to the pSXXF motif and intramolecular hydrogen bonds that can be exploited during inhibitor design.
引用
收藏
页码:10658 / +
页数:3
相关论文
共 21 条
[1]   Generation of ligand binding sites in T4 lysozyme by deficiency-creating substitutions [J].
Baldwin, E ;
Baase, WA ;
Zhang, XJ ;
Feher, V ;
Matthews, BW .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 277 (02) :467-485
[2]   Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains [J].
Botuyan, MVE ;
Nominé, Y ;
Yu, XC ;
Juranic, N ;
Macura, S ;
Chen, JJ ;
Mer, G .
STRUCTURE, 2004, 12 (07) :1137-1146
[3]   BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function [J].
Cantor, SB ;
Bell, DW ;
Ganesan, S ;
Kass, EM ;
Drapkin, R ;
Grossman, S ;
Wahrer, DCR ;
Sgroi, DC ;
Lane, WS ;
Haber, DA ;
Livingston, DM .
CELL, 2001, 105 (01) :149-160
[4]   Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer [J].
Clapperton, JA ;
Manke, IA ;
Lowery, DM ;
Ho, T ;
Haire, LF ;
Yaffe, MB ;
Smerdon, SJ .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2004, 11 (06) :512-518
[5]  
DELANO WL, 1998, PYMOL USERS MANUAL
[6]  
Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO
[7]  
2-W
[8]   Interactions between BRCT repeats and phosphoproteins: tangled up in two [J].
Glover, JNM ;
Williams, RS ;
Lee, MS .
TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (11) :579-585
[9]   High-throughput fluorescence polarization assay to identify small molecule inhibitors of BRCT domains of breast cancer gene 1 [J].
Lokesh, GL ;
Rachamallu, A ;
Kumar, GDK ;
Natarajan, A .
ANALYTICAL BIOCHEMISTRY, 2006, 352 (01) :135-141
[10]   BRCT repeats as phosphopeptide-binding modules involved in protein targeting [J].
Manke, IA ;
Lowery, DM ;
Nguyen, A ;
Yaffe, MB .
SCIENCE, 2003, 302 (5645) :636-639